Cargando…
Exploring the implications of modified risk claim placement in tobacco advertising
The United States Food and Drug Administration (FDA) has developed a regulatory process by which tobacco companies can apply to make “modified risk tobacco product” (MRTP) marketing claims that their product poses a lower risk of disease or exposure to harmful constituents. The impact of MRTP claims...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684010/ https://www.ncbi.nlm.nih.gov/pubmed/34976664 http://dx.doi.org/10.1016/j.pmedr.2021.101608 |